title: Breakthrough targeted therapeutic approaches to squamous cell carcinoma of the head and neck.
authors.affiliation: First Department of General Surgery, Ospedale di Circolo e Fondazione Macchi Varese, Department of Morphological & Surgical Sciences, Endocrine Surgery Research Center, Insubria University, Varese-Como, Italy.
authors.forename: Alberto
authors.initials: A
authors.lastname: Mangano
authors.forename: Alessandro
authors.initials: A
authors.lastname: Mangano
authors.forename: Georgios D
authors.initials: GD
authors.lastname: Lianos
authors.forename: Dimitrios H
authors.initials: DH
authors.lastname: Roukos
authors.forename: Alberto
authors.initials: A
authors.lastname: Caprioglio
authors.forename: Gianlorenzo
authors.initials: G
authors.lastname: Dionigi
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006258:Head and Neck Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000473:pathology; D006801:Humans; D047428:Protein Kinase Inhibitors / Q000276:immunology / Q000627:therapeutic use*; D000077195:Squamous Cell Carcinoma of Head and Neck
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors
keywords: head and neck squamous cell carcinoma; monoclonal antibodies; targeted treatment; tyrosine kinase inhibitors